Multiomics – News and Features

In this article, Asim Siddiqui explores the emerging ability of proteomics to reveal new biomarkers for disease.

Columbia researchers have found that Lgr5+ cells descend from the gut’s true stem cells. This case of mistaken identity may explain why regenerative medicine has not lived up to its promise.

Researchers from the Icahn School of Medicine at Mount Sinai have shed valuable light on the nuanced functions and intricate regulatory methods of RNA editing, a critical mechanism underlying brain development and disease.

In this opinion piece, Markus Gershater provides a comprehensive look into the current state and immense potential of artificial intelligence in reshaping the landscape of drug discovery.

Amyotrophic lateral sclerosis (ALS) is an almost always fatal neurodegenerative disease. Researchers have now discovered that ALS can be divided into subtypes and that there are clear differences in the molecular processes between men and women.

The structure and function of the kidneys is altered by space flight, with galactic radiation causing permanent damage that would jeopardise any mission to Mars, according to a new study led by researchers from UCL.

A multiomics approach has identified four distinct molecular profiles of Alzheimer's, one of which was associated with worse cognitive function.

John Lesica, president of chromatography and mass spectrometry at Thermo Fisher Scientific, joined Technology Networks for an interview at this year's American Society for Mass Spectrometry event.

In this article, we take a look at the latest advancements in research applying multiplex CRISPR-Cas9 genome editing to plants.

Whole-body models (WBMs) are computational models that integrate different types of multiomics data such as genomic, metabolic and proteomic insights, and have been created to simulate and study adult physiology and disease. WBMs for newborns, however, are currently lacking – until now.